 | • レポートコード：QYR9ST03383 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、アンチセンス及びRNAi治療薬の世界市場について調査・分析し、アンチセンス及びRNAi治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（RNA干渉、SiRNA、MiRNA、アンチセンスRNA）、用途別（腫瘍学、心血管、腎、神経変性、呼吸器、遺伝的）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアンチセンス及びRNAi治療薬市場動向 ・主要企業別マーケットシェア ・アンチセンス及びRNAi治療薬の種類別市場規模2014-2019 （RNA干渉、SiRNA、MiRNA、アンチセンスRNA） ・アンチセンス及びRNAi治療薬の用途別市場規模2014-2019 （腫瘍学、心血管、腎、神経変性、呼吸器、遺伝的） ・アンチセンス及びRNAi治療薬の北米市場：主要企業・種類別/用途別市場規模 ・アンチセンス及びRNAi治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・アンチセンス及びRNAi治療薬の中国市場：主要企業・種類別/用途別市場規模 ・アンチセンス及びRNAi治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・アンチセンス及びRNAi治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・アンチセンス及びRNAi治療薬のインド市場：主要企業・種類別/用途別市場規模 ・アンチセンス及びRNAi治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Glaxo Smith Kline、Sanofi Aventis / Genzyme、Isis Pharmaceuticals/ Ionis Pharmaceuticals、Arbutus Biopharma Ltd.、Silence Therapeutics、Bio-Path Holdings Inc.、Calando Pharmaceuticals、ICo Therapeutics、Quark Pharmaceuticals、Rexhan Pharmaceuticals、Biomarin/Prosensa、Regulus Therapeutics、Rxi Pharmaceuticals、Silenseed、Dicerna Pharmaceuticals、Sirnaomics Inc.） ・アンチセンス及びRNAi治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene “off”.North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.
In 2018, the global Antisense & RNAi Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Antisense & RNAi Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antisense & RNAi Therapeutics development in United States, Europe and China.
The key players covered in this study
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.
Market segment by Type, the product can be split into
RNA interference
SiRNA
MiRNA
Antisense RNA
Market segment by Application, split into
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Antisense & RNAi Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Antisense & RNAi Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Antisense & RNAi Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Antisense & RNAi Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 RNA interference
1.4.3 SiRNA
1.4.4 MiRNA
1.4.5 Antisense RNA
1.5 Market by Application
1.5.1 Global Antisense & RNAi Therapeutics Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Cardiovascular
1.5.4 Renal
1.5.5 Neurodegenerative
1.5.6 Respiratory
1.5.7 Genetic
1.5.8 Infectious Diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Antisense & RNAi Therapeutics Market Size
2.2 Antisense & RNAi Therapeutics Growth Trends by Regions
2.2.1 Antisense & RNAi Therapeutics Market Size by Regions (2014-2025)
2.2.2 Antisense & RNAi Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Antisense & RNAi Therapeutics Market Size by Manufacturers
3.1.1 Global Antisense & RNAi Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Antisense & RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Antisense & RNAi Therapeutics Key Players Head office and Area Served
3.3 Key Players Antisense & RNAi Therapeutics Product/Solution/Service
3.4 Date of Enter into Antisense & RNAi Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Antisense & RNAi Therapeutics Market Size by Type (2014-2019)
4.2 Global Antisense & RNAi Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Antisense & RNAi Therapeutics Market Size (2014-2019)
5.2 Antisense & RNAi Therapeutics Key Players in United States
5.3 United States Antisense & RNAi Therapeutics Market Size by Type
5.4 United States Antisense & RNAi Therapeutics Market Size by Application
6 Europe
6.1 Europe Antisense & RNAi Therapeutics Market Size (2014-2019)
6.2 Antisense & RNAi Therapeutics Key Players in Europe
6.3 Europe Antisense & RNAi Therapeutics Market Size by Type
6.4 Europe Antisense & RNAi Therapeutics Market Size by Application
7 China
7.1 China Antisense & RNAi Therapeutics Market Size (2014-2019)
7.2 Antisense & RNAi Therapeutics Key Players in China
7.3 China Antisense & RNAi Therapeutics Market Size by Type
7.4 China Antisense & RNAi Therapeutics Market Size by Application
8 Japan
8.1 Japan Antisense & RNAi Therapeutics Market Size (2014-2019)
8.2 Antisense & RNAi Therapeutics Key Players in Japan
8.3 Japan Antisense & RNAi Therapeutics Market Size by Type
8.4 Japan Antisense & RNAi Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Antisense & RNAi Therapeutics Market Size (2014-2019)
9.2 Antisense & RNAi Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Antisense & RNAi Therapeutics Market Size by Type
9.4 Southeast Asia Antisense & RNAi Therapeutics Market Size by Application
10 India
10.1 India Antisense & RNAi Therapeutics Market Size (2014-2019)
10.2 Antisense & RNAi Therapeutics Key Players in India
10.3 India Antisense & RNAi Therapeutics Market Size by Type
10.4 India Antisense & RNAi Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Antisense & RNAi Therapeutics Market Size (2014-2019)
11.2 Antisense & RNAi Therapeutics Key Players in Central & South America
11.3 Central & South America Antisense & RNAi Therapeutics Market Size by Type
11.4 Central & South America Antisense & RNAi Therapeutics Market Size by Application
12 International Players Profiles
12.1 Glaxo Smith Kline
12.1.1 Glaxo Smith Kline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Antisense & RNAi Therapeutics Introduction
12.1.4 Glaxo Smith Kline Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.1.5 Glaxo Smith Kline Recent Development
12.2 Sanofi Aventis / Genzyme
12.2.1 Sanofi Aventis / Genzyme Company Details
12.2.2 Company Description and Business Overview
12.2.3 Antisense & RNAi Therapeutics Introduction
12.2.4 Sanofi Aventis / Genzyme Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.2.5 Sanofi Aventis / Genzyme Recent Development
12.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
12.3.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Antisense & RNAi Therapeutics Introduction
12.3.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.3.5 Isis Pharmaceuticals/ Ionis Pharmaceuticals Recent Development
12.4 Arbutus Biopharma Ltd.
12.4.1 Arbutus Biopharma Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Antisense & RNAi Therapeutics Introduction
12.4.4 Arbutus Biopharma Ltd. Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.4.5 Arbutus Biopharma Ltd. Recent Development
12.5 Silence Therapeutics
12.5.1 Silence Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Antisense & RNAi Therapeutics Introduction
12.5.4 Silence Therapeutics Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.5.5 Silence Therapeutics Recent Development
12.6 Bio-Path Holdings Inc.
12.6.1 Bio-Path Holdings Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Antisense & RNAi Therapeutics Introduction
12.6.4 Bio-Path Holdings Inc. Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.6.5 Bio-Path Holdings Inc. Recent Development
12.7 Calando Pharmaceuticals
12.7.1 Calando Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Antisense & RNAi Therapeutics Introduction
12.7.4 Calando Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.7.5 Calando Pharmaceuticals Recent Development
12.8 ICo Therapeutics
12.8.1 ICo Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Antisense & RNAi Therapeutics Introduction
12.8.4 ICo Therapeutics Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.8.5 ICo Therapeutics Recent Development
12.9 Quark Pharmaceuticals
12.9.1 Quark Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Antisense & RNAi Therapeutics Introduction
12.9.4 Quark Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.9.5 Quark Pharmaceuticals Recent Development
12.10 Rexhan Pharmaceuticals
12.10.1 Rexhan Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Antisense & RNAi Therapeutics Introduction
12.10.4 Rexhan Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.10.5 Rexhan Pharmaceuticals Recent Development
12.11 Biomarin/Prosensa
12.12 Regulus Therapeutics
12.13 Rxi Pharmaceuticals
12.14 Silenseed
12.15 Dicerna Pharmaceuticals
12.16 Sirnaomics Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Antisense & RNAi Therapeutics Key Market Segments
Table Key Players Antisense & RNAi Therapeutics Covered
Table Global Antisense & RNAi Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Antisense & RNAi Therapeutics Market Size Market Share by Type 2014-2025
Figure RNA interference Figures
Table Key Players of RNA interference
Figure SiRNA Figures
Table Key Players of SiRNA
Figure MiRNA Figures
Table Key Players of MiRNA
Figure Antisense RNA Figures
Table Key Players of Antisense RNA
Table Global Antisense & RNAi Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Oncology Case Studies
Figure Cardiovascular Case Studies
Figure Renal Case Studies
Figure Neurodegenerative Case Studies
Figure Respiratory Case Studies
Figure Genetic Case Studies
Figure Infectious Diseases Case Studies
Figure Antisense & RNAi Therapeutics Report Years Considered
Table Global Antisense & RNAi Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Antisense & RNAi Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Antisense & RNAi Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Antisense & RNAi Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Antisense & RNAi Therapeutics Market Share by Regions 2014-2019
Figure Global Antisense & RNAi Therapeutics Market Share by Regions 2014-2019
Figure Global Antisense & RNAi Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Antisense & RNAi Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Antisense & RNAi Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Antisense & RNAi Therapeutics Market Share by Manufacturers in 2018
Table Global Antisense & RNAi Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Antisense & RNAi Therapeutics Product/Solution/Service
Table Date of Enter into Antisense & RNAi Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Antisense & RNAi Therapeutics Market Size Share by Type (2014-2019)
Figure Global Antisense & RNAi Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Antisense & RNAi Therapeutics Market Size Share by Application (2014-2019)
Figure Global Antisense & RNAi Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Application in 2018
Figure United States Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table United States Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table United States Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Figure Europe Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table Europe Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table Europe Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Figure China Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table China Antisense & RNAi Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table China Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Figure Japan Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table Japan Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table Japan Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table Southeast Asia Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Figure India Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table India Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table India Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Antisense & RNAi Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Antisense & RNAi Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Antisense & RNAi Therapeutics Market Share (2018-2019)
Table Central & South America Antisense & RNAi Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Antisense & RNAi Therapeutics Market Share by Type (2014-2019)
Table Central & South America Antisense & RNAi Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Antisense & RNAi Therapeutics Market Share by Application (2014-2019)
Table Glaxo Smith Kline Company Details
Table Glaxo Smith Kline Revenue in Antisense & RNAi Therapeutics Business (2014-2019) (Million US$)
Figure Glaxo Smith Kline Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Glaxo Smith Kline Recent Development
Table Sanofi Aventis / Genzyme Company Details
Table Sanofi Aventis / Genzyme Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Aventis / Genzyme Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Sanofi Aventis / Genzyme Recent Development
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Details
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Isis Pharmaceuticals/ Ionis Pharmaceuticals Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Recent Development
Table Arbutus Biopharma Ltd. Company Details
Table Arbutus Biopharma Ltd. Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Arbutus Biopharma Ltd. Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Arbutus Biopharma Ltd. Recent Development
Table Silence Therapeutics Company Details
Table Silence Therapeutics Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Silence Therapeutics Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Silence Therapeutics Recent Development
Table Bio-Path Holdings Inc. Company Details
Table Bio-Path Holdings Inc. Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Bio-Path Holdings Inc. Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Bio-Path Holdings Inc. Recent Development
Table Calando Pharmaceuticals Company Details
Table Calando Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Calando Pharmaceuticals Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Calando Pharmaceuticals Recent Development
Table ICo Therapeutics Company Details
Table ICo Therapeutics Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure ICo Therapeutics Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table ICo Therapeutics Recent Development
Table Quark Pharmaceuticals Company Details
Table Quark Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Quark Pharmaceuticals Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Quark Pharmaceuticals Recent Development
Table Rexhan Pharmaceuticals Company Details
Table Rexhan Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)(Million US$)
Figure Rexhan Pharmaceuticals Revenue Growth Rate in Antisense & RNAi Therapeutics Business (2014-2019)
Table Rexhan Pharmaceuticals Recent Development
Table Biomarin/Prosensa Company Details
Table Regulus Therapeutics Company Details
Table Rxi Pharmaceuticals Company Details
Table Silenseed Company Details
Table Dicerna Pharmaceuticals Company Details
Table Sirnaomics Inc. Company Details
Table Global Antisense & RNAi Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Antisense & RNAi Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Antisense & RNAi Therapeutics Market Size Share by Regions in 2025
Figure United States Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Antisense & RNAi Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Antisense & RNAi Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Antisense & RNAi Therapeutics Market Size by Product (2019-2025)
Figure Global Antisense & RNAi Therapeutics Market Size by Product in 2025
Table Global Antisense & RNAi Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Antisense & RNAi Therapeutics Market Size by Application (2019-2025)
Figure Global Antisense & RNAi Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
オリゴヌクレオチド治療薬の世界市場：市場規模・現状・予測 Oligonucleotides are short nucleotides sequences of DNA or RNA molecules called oligomers. Oligonucleotide therapeutics target and inhibit the expression of certain diseases-causing genes, thus forming a new class of therapeutics to treat chronic diseases.In terms of geographic regions, the North Am…- RNAi技術の世界市場：インサイト・予測 RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinan…
- 糖尿病性網膜症の世界市場：市場規模・現状・予測 Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…
- 急性腎不全治療薬の世界市場：市場規模・現状・予測 Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.Acute ren…
- 進行腎細胞癌治療薬の世界市場：市場規模・現状・予測 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …